ZA945774B - Benzopyrans - Google Patents
BenzopyransInfo
- Publication number
- ZA945774B ZA945774B ZA945774A ZA945774A ZA945774B ZA 945774 B ZA945774 B ZA 945774B ZA 945774 A ZA945774 A ZA 945774A ZA 945774 A ZA945774 A ZA 945774A ZA 945774 B ZA945774 B ZA 945774B
- Authority
- ZA
- South Africa
- Prior art keywords
- disease
- compounds
- motility
- asthma
- hypertension
- Prior art date
Links
- 150000001562 benzopyrans Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 208000012258 Diverticular disease Diseases 0.000 abstract 1
- 206010013554 Diverticulum Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 206010030136 Oesophageal achalasia Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000004899 motility Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000002460 smooth muscle Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939316111A GB9316111D0 (en) | 1993-08-04 | 1993-08-04 | Benzopyrans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA945774B true ZA945774B (en) | 1996-02-05 |
Family
ID=10739921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA945774A ZA945774B (en) | 1993-08-04 | 1994-08-03 | Benzopyrans |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US5912244A (es) |
| EP (1) | EP0712398B1 (es) |
| JP (1) | JP2871098B2 (es) |
| KR (1) | KR0175532B1 (es) |
| CN (1) | CN1128536A (es) |
| AT (1) | ATE152716T1 (es) |
| AU (1) | AU684817B2 (es) |
| CA (1) | CA2168563C (es) |
| CO (1) | CO4230234A1 (es) |
| CZ (1) | CZ281853B6 (es) |
| DE (1) | DE69403084T2 (es) |
| DK (1) | DK0712398T3 (es) |
| EC (1) | ECSP941140A (es) |
| EG (1) | EG20525A (es) |
| ES (1) | ES2102870T3 (es) |
| FI (1) | FI960487A0 (es) |
| GB (1) | GB9316111D0 (es) |
| GR (1) | GR3023521T3 (es) |
| HU (1) | HUT75120A (es) |
| IL (1) | IL110488A (es) |
| NO (1) | NO960441L (es) |
| NZ (1) | NZ271344A (es) |
| PE (1) | PE56894A1 (es) |
| PL (1) | PL312788A1 (es) |
| SG (1) | SG42817A1 (es) |
| TW (1) | TW333532B (es) |
| WO (1) | WO1995004730A1 (es) |
| ZA (1) | ZA945774B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5573758A (en) * | 1995-04-28 | 1996-11-12 | Allergan | Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers |
| US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
| DE69722202T2 (de) * | 1996-06-07 | 2004-04-01 | Vanderbilt University, Nashville | Dihydrobenzopyran und ähnliche verbindungen verwendbar als antientzündungsmittel |
| US6333352B1 (en) * | 2000-04-05 | 2001-12-25 | Mimicking Man Manually, Inc. | Method of treating benign positional vertigo |
| PL207255B1 (pl) * | 2001-04-16 | 2010-11-30 | Pharmacopeia Drug Discovery | 3,4-di-podstawione cyklobuten-1,2-diony i ich zastosowanie oraz zawierająca je kompozycja farmaceutyczna |
| JP2005505586A (ja) * | 2001-10-04 | 2005-02-24 | ワイス | ５−ヒドロキシトリプタミン−６リガンドとしてのクロマン誘導体 |
| US7306789B2 (en) * | 2002-11-12 | 2007-12-11 | Warner-Lambert Company, Llc | Method of stimulating hair growth using benzopyrans |
| CA2555741C (en) * | 2004-02-12 | 2010-03-23 | Warner-Lambert Company Llc | Method of stimulating hair growth |
| US20090110892A1 (en) * | 2004-06-30 | 2009-04-30 | General Electric Company | System and method for making a graded barrier coating |
| EP1773820A1 (en) * | 2004-07-16 | 2007-04-18 | Warner-Lambert Company LLC | Hair growth promoting agents |
| MXPA06014390A (es) * | 2004-07-19 | 2007-10-02 | Warner Lambert Co | Formulacion para estimular el crecimiento del pelo. |
| KR100965190B1 (ko) * | 2004-12-21 | 2010-06-24 | 에프. 호프만-라 로슈 아게 | 크로만 유도체 및 중추 신경계 장애의 치료에서 그의 용도 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3835011A1 (de) * | 1988-10-14 | 1990-04-19 | Merck Patent Gmbh | Chromanderivate |
| DE3881714D1 (de) * | 1987-02-04 | 1993-07-22 | Hoechst Ag | Alkylsubstituierte n-benzopyranyllactame, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen. |
| DE3703227A1 (de) * | 1987-02-04 | 1988-08-18 | Hoechst Ag | Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen |
| DE3811017A1 (de) * | 1988-03-31 | 1989-10-19 | Hoechst Ag | Ungesaettigte n-benzopyranyllactame |
| AU628331B2 (en) * | 1988-05-06 | 1992-09-17 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Chroman derivatives |
| EP0346724A1 (de) * | 1988-06-16 | 1989-12-20 | MERCK PATENT GmbH | Chromanderivate |
| DE3824446A1 (de) * | 1988-07-19 | 1990-01-25 | Hoechst Ag, 6230 Frankfurt | Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege |
| DE3827532A1 (de) * | 1988-08-13 | 1990-03-01 | Hoechst Ag | 6-aroyl-substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen |
| DE3918041A1 (de) * | 1989-06-02 | 1990-12-06 | Merck Patent Gmbh | Chromanderivate |
| US5061813A (en) * | 1990-04-02 | 1991-10-29 | E. R. Squibb & Sons, Inc. | Substituted cyanoimino benzopyranes |
| GB2242628A (en) * | 1990-04-06 | 1991-10-09 | Sandoz Ltd | Asthma prophylactic use of K+ channel activators |
| TW244350B (es) * | 1991-12-14 | 1995-04-01 | Hoechst Ag | |
| JPH0673061A (ja) * | 1992-01-18 | 1994-03-15 | Hoechst Ag | ６−置換クロメン類のエナンチオ選択的エポキシ化方法 |
-
1993
- 1993-08-04 GB GB939316111A patent/GB9316111D0/en active Pending
-
1994
- 1994-07-08 TW TW083106236A patent/TW333532B/zh active
- 1994-07-18 KR KR1019960700566A patent/KR0175532B1/ko not_active IP Right Cessation
- 1994-07-18 AU AU74948/94A patent/AU684817B2/en not_active Ceased
- 1994-07-18 SG SG1995002213A patent/SG42817A1/en unknown
- 1994-07-18 DE DE69403084T patent/DE69403084T2/de not_active Expired - Fee Related
- 1994-07-18 ES ES94924788T patent/ES2102870T3/es not_active Expired - Lifetime
- 1994-07-18 PL PL94312788A patent/PL312788A1/xx unknown
- 1994-07-18 DK DK94924788.6T patent/DK0712398T3/da active
- 1994-07-18 CA CA002168563A patent/CA2168563C/en not_active Expired - Fee Related
- 1994-07-18 WO PCT/EP1994/002387 patent/WO1995004730A1/en active IP Right Grant
- 1994-07-18 JP JP7506179A patent/JP2871098B2/ja not_active Expired - Fee Related
- 1994-07-18 EP EP94924788A patent/EP0712398B1/en not_active Expired - Lifetime
- 1994-07-18 CN CN94192981A patent/CN1128536A/zh active Pending
- 1994-07-18 NZ NZ271344A patent/NZ271344A/en unknown
- 1994-07-18 AT AT94924788T patent/ATE152716T1/de not_active IP Right Cessation
- 1994-07-18 US US08/591,500 patent/US5912244A/en not_active Expired - Fee Related
- 1994-07-18 CZ CZ96331A patent/CZ281853B6/cs not_active IP Right Cessation
- 1994-07-18 HU HU9600238A patent/HUT75120A/hu unknown
- 1994-07-25 PE PE1994247480A patent/PE56894A1/es not_active Application Discontinuation
- 1994-07-28 IL IL11048894A patent/IL110488A/xx not_active IP Right Cessation
- 1994-08-03 ZA ZA945774A patent/ZA945774B/xx unknown
- 1994-08-03 EG EG46794A patent/EG20525A/xx active
- 1994-08-04 EC EC1994001140A patent/ECSP941140A/es unknown
- 1994-08-04 CO CO94034292A patent/CO4230234A1/es unknown
-
1996
- 1996-02-02 NO NO960441A patent/NO960441L/no not_active Application Discontinuation
- 1996-02-02 FI FI960487A patent/FI960487A0/fi unknown
-
1997
- 1997-05-23 GR GR970401169T patent/GR3023521T3/el unknown
-
1999
- 1999-04-09 US US09/288,975 patent/US6071938A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9705590A (es) | Compuestos heterociclicos sustituidos, procedimiento para su preparacion y composiciones que los contienen. | |
| EG20525A (en) | Benzopyrans | |
| DE69705829D1 (de) | Meta-substituierte phenylsulphonamidderivate | |
| AU2337097A (en) | Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors | |
| BG100951A (en) | Novel erythromycin derivatives, method for their preparation and their use as drugs | |
| SG48750A1 (en) | Tricyclic carbonate compounds useful for inhabition of g-protein function for treatment of proliferative diseases | |
| CA2211522A1 (en) | Novel compounds | |
| MX9804046A (es) | 6-0-metil eritromicina d y proceso para hacerla. | |
| AU672052B2 (en) | Antidepressant and antiparkinsonian compounds | |
| FI902632A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 5-substitoitujen 5,11-dihydrodibentso/b,e//1,4/tiatsepiinijohdannaisten valmistamiseksi sekä menetelmässä käyttökelpoisia välituotteita | |
| FI935799A (fi) | Aryylisubstituoituja heterosyklisiä yhdisteitä | |
| DK0604355T3 (da) | Arylsubstituerede heterocykliske forbindelser | |
| TW339325B (en) | Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same | |
| CA2276203A1 (en) | N-(pyridinylamino)isoindolines and related compounds | |
| GB2333294A (en) | Cytokine production inhibitors | |
| DE69418715D1 (en) | Erythromycinderivate | |
| AU5334196A (en) | Method for the preparation of esters of anhydroecgonine |